Clinical TrialID 7972

Comparison of Azelaic Acid 20 % Cream Versus Hydroquinone 4% Cream as an Adjuvant to Oral Tranexamic Acid in Melasma

NCT05887219

Melasma

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
7972
Evidence Id
7972
Core Evidence Id
7972
Source Clinical Trial Id
7968
Herb2 Clinical Trial Id
HBCT007968
Nct Id
NCT05887219
Title
Comparison of Azelaic Acid 20 % Cream Versus Hydroquinone 4% Cream as an Adjuvant to Oral Tranexamic Acid in Melasma
Status
Completed
Phase
Phase 1
Study Result
No
Study Condition
Melasma
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Intervention
DRUG: Group A 4 % Hydroquinone Cream Topically and Oral Tranexamic Acid|DRUG: Group B Azelaic Acid 20 % Cream for 6 months
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Intervention Purpose
Treatment
Gender
Female
Age
Adult
Enrollment
50
Outcome Measure
Melasma Area and Severity Index, Melasma Area and Severity Index Score was used to assess response to treatment.Lowest score=0,Highest Score 48. High score indicates worse outcome., 6 months
Sponsor Collaborator
Combined Military Hospital Abbottabad
Funded By
OTHER
Location
Zahra Nigar, Abbottabad, KPK, 22010, Pakistan
Other Id
CMHAbbottabad1987
Start Date
2022-11-01
Primary Completion Date
2023-04-30
Completion Date
2023-04-30
First Posted
2023-06-02
Results First Posted
Last Update Posted
2023-06-02
Study Document
Study Url
https://clinicaltrials.gov/study/NCT05887219
Title Cn
Title En
Comparison of Azelaic Acid 20 % Cream Versus Hydroquinone 4% Cream as an Adjuvant to Oral Tranexamic Acid in Melasma
Bilingual Status
semi_complete